| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/20/2004 | US20040094449 Melatonin daily dosage units |
| 05/20/2004 | US20040094145 Consist wholly or partly of linear polysaccharides, in particular 1,4- alpha -D-polyglucan |
| 05/20/2004 | US20040093795 Floral packaging material having great masters prints thereon |
| 05/20/2004 | CA2448809A1 Pressure-sensitive adhesive sheet for medical use and process for producing the same |
| 05/19/2004 | EP1420025A1 Powder comprising water-containing beta-maltose crystals and production process and use thereof |
| 05/19/2004 | EP1420010A1 Amphoteric lipid compound and use thereof |
| 05/19/2004 | EP1419803A2 Pharmaceutical composition for topical administration comprising an antiviral substance and a glucocorticoid |
| 05/19/2004 | EP1419790A1 A solution comprising an olefinic diol and a pharmaceutically active compound |
| 05/19/2004 | EP1419789A2 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these |
| 05/19/2004 | EP1419784A2 Proteosome vaccines against toxins, allergy and cancer |
| 05/19/2004 | EP1419782A1 Use of consensus interferon for reducing the side-effects of interferon treatment in viral hepatitis |
| 05/19/2004 | EP1419778A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1419776A2 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/19/2004 | EP1419775A1 Pharmaceutical preparations containing aminobenzene-sulfonic acid derivatives as the active ingredient |
| 05/19/2004 | EP1419774A1 Pharmaceutical formulations and methods comprising intranasal morphine |
| 05/19/2004 | EP1419766A1 Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
| 05/19/2004 | EP1419765A1 Process for manufacturing a solid dosage form comprising an effervescent couple for buccal, gingival or sublingual administration |
| 05/19/2004 | EP1419386A1 Method for producing microparticles loaded with proteins |
| 05/19/2004 | EP1419173A2 Peptides that bind to atherosclerotic lesions |
| 05/19/2004 | EP1419005A1 Stable coated microcapsules |
| 05/19/2004 | EP1418951A1 Transdermal therapeutic system (tts) with fentanyl as active ingredient |
| 05/19/2004 | EP1418946A2 Bioactive surface modifiers for polymers and articles made therefrom |
| 05/19/2004 | EP1418945A2 Micellar drug delivery vehicles and uses thereof |
| 05/19/2004 | EP1418942A2 Poxvirus-containing compositions and process for their preparation |
| 05/19/2004 | EP1418939A2 Calcium phosphate particles as mucosal adjuvants |
| 05/19/2004 | EP1418922A1 Compositions comprising negatively charched phospholipids for treatment and/or prevention of macular degeneration and method for its manufacture |
| 05/19/2004 | EP1418919A2 The use of 5 fluorourcil, delivered by inotophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skin |
| 05/19/2004 | EP1418918A2 Compositions and methods for targeting cerebral circulation and treatment of headache |
| 05/19/2004 | EP1418914A2 Mucin synthesis inhibitors |
| 05/19/2004 | EP1418903A2 Prostanoids augment ocular drug penetration |
| 05/19/2004 | EP1418898A1 Use of dmso in the treatment of neurodegenerative diseases caused by prions |
| 05/19/2004 | EP1418896A2 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 05/19/2004 | EP1418895A1 Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups |
| 05/19/2004 | EP1418894A2 Transdermal therapeutic system with fentanyl or related substances |
| 05/19/2004 | EP1418893A1 Compositions and techniques for localized therapy of restenosis |
| 05/19/2004 | EP1418892A1 Synergistic mixed poloxamer systems for the solubilisation of drugs |
| 05/19/2004 | EP1418891A1 Anaesthetic formulations of propofol |
| 05/19/2004 | EP1418890A1 Propellant-based microparticle formulations |
| 05/19/2004 | EP1418889A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 05/19/2004 | EP1418888A1 Breath freshening film |
| 05/19/2004 | EP1418880A1 Oral rinse for treatment or prevention of bacterial and fungal infection |
| 05/19/2004 | EP1418869A1 Kavalactone compositions and methods of use |
| 05/19/2004 | EP1418864A1 Method and intra sclera implant for treatment of glaucoma and presbyopia |
| 05/19/2004 | EP1418862A2 Individualized addiction cessation therapy |
| 05/19/2004 | EP1418860A2 Oral care substance delivery strip |
| 05/19/2004 | EP1299287A4 Methods of producing a terminally sterilized topical patch preparation |
| 05/19/2004 | EP1292539B1 Micronised barium sulphate |
| 05/19/2004 | EP1265618A4 Anaesthetic composition |
| 05/19/2004 | EP1235555B1 Stable galenic preparations comprising a benzimidazol and method for the production thereof |
| 05/19/2004 | EP1220849B1 Bicyclic compounds composition and method for stabilizing the same |
| 05/19/2004 | EP1204416A4 Carnitine analogues as topical, microbicidal spermicides |
| 05/19/2004 | EP1200100A4 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration |
| 05/19/2004 | EP1137373A4 Biocompatible crosslinked polymers |
| 05/19/2004 | EP1128811B1 Drug delivery device, especially for the delivery of progestins and estrogens |
| 05/19/2004 | EP1096922A4 Improved stable topical ascorbic acid compositions |
| 05/19/2004 | EP1041978A4 Methods of inactivating bacteria including bacterial spores |
| 05/19/2004 | EP1007551B1 Vaccine against hpv |
| 05/19/2004 | EP0966273B1 Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties |
| 05/19/2004 | EP0817655B1 Intrapulmonary delivery of hematopoietic drug |
| 05/19/2004 | EP0683632B1 Dry powder delivery system |
| 05/19/2004 | DE60100389T2 Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung Fat-soluble substances containing granules, and processes for their preparation |
| 05/19/2004 | DE20220838U1 Orale Arzneiform enthaltend einen therapeutischen Wirkstoff und ein Gegenwirkungsmittel Oral dosage form containing a therapeutic agent and a counteracting means |
| 05/19/2004 | DE10251963A1 Wafer-form transmucosal dosage form, comprising solution of active agent, e.g. for combating drug abuse, in phosphatidyl choline fraction, providing both rapid and constant release via the oral cavity |
| 05/19/2004 | DE10250711A1 Pharmazeutische und kosmetische Zubereitungen Pharmaceutical and cosmetic preparations |
| 05/19/2004 | DE10250543A1 Mehrschichtige Arzneiform Multilayer dosage form |
| 05/19/2004 | DE10236564A1 Verwendung von papaverinartigem Vasodilatator und pharmazeutische Zusammensetzung Use of papaverinartigem vasodilator and pharmaceutical composition |
| 05/19/2004 | CN1498114A Pharmaceutical composition having reduced tendency for drug crystallization |
| 05/19/2004 | CN1498113A Insulin preparations, which donot contain any zinc or only small quantity of zinc of improved stability |
| 05/19/2004 | CN1498106A Pharmaceutical forms of epothilones for oral administration |
| 05/19/2004 | CN1498096A Condom with erectogenic composition |
| 05/19/2004 | CN1498080A One-step process for preparing gum |
| 05/19/2004 | CN1496743A Medicine composition of adding active component which undissolved in water in carrier composition and its preparing method |
| 05/19/2004 | CN1496742A Medicine composition of macrolides or cyclosporin and polyoxide saturated hydoxy fatty acid |
| 05/19/2004 | CN1496741A Method for producing enteric nutrient containing malt ketose |
| 05/19/2004 | CN1496738A Fenofibrate medicine composition with high bio-availability and preparation method thereof |
| 05/19/2004 | CN1496737A Method for treating inflammation of muscular skeleton and connective tissue |
| 05/19/2004 | CN1496733A Cosmetic and/or skin applied of composition containing easy oxidation hydrophilic active component stablized by maleic anhydride copolymer |
| 05/19/2004 | CN1150033C Immunopptentiating composition |
| 05/19/2004 | CN1150031C Use of histamine of therapeutic purposes |
| 05/19/2004 | CN1150021C Capsule for treating peptic ulcer and its preparation method |
| 05/19/2004 | CN1150011C 'Qingzhang Mingmu' pills for clearing eyes and its preparation method |
| 05/19/2004 | CN1150001C Injections contg. lipid A analogues and process for preparation thereof |
| 05/19/2004 | CN1150000C Compositions containing diphosphonic acids |
| 05/19/2004 | CN1149999C Pharmaceutical composition containing vitamin D and calcium, their preparation and therapeutic use |
| 05/19/2004 | CN1149998C New use of budesonide and formoterol |
| 05/19/2004 | CN1149997C Medicine composition |
| 05/19/2004 | CN1149994C Oral compositions of levosimendan |
| 05/19/2004 | CN1149993C Pharmaceutical moxifloxacin preparation |
| 05/19/2004 | CN1149992C Antimycotic gel with active substance release |
| 05/19/2004 | CN1149987C Pharmaceutical composition comprising combination of dextro-and laevo-isomers of sotalol |
| 05/19/2004 | CN1149984C Anesthetic compsn. for intravenous injection comprising propofol |
| 05/19/2004 | CN1149983C Compositions and methos for treatment of anorectal disorders |
| 05/19/2004 | CN1149982C Controlled releasing of steroid from sugarcoating |
| 05/19/2004 | CN1149981C Product with powder stable vitamine and/or carotenoid its producing process |
| 05/19/2004 | CN1149980C Spray-dried powders with high edible-oil loading based on non-bydrolyzed gelation and method of making such spry-dried tablettable powders |
| 05/19/2004 | CN1149979C Medicinal composition |
| 05/19/2004 | CN1149978C Quinolone-containing liposome composition and their preparation method |
| 05/19/2004 | CN1149977C Pharmaceutical compositions in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 05/19/2004 | CN1149976C Adhesive polymer substrate and its application |
| 05/19/2004 | CN1149975C Compositions containing a peptide and polylactic-glycolic acid subitable for preparing subcutaneous implants with and extended release period |